The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy

他のバージョン（1件）を表示する

Renin-angiotensin-aldosterone system inhibitors prevent the progression of kidney disease in patients with diabetic nephropathy, and we studied how that benefit varies by the type of diabetes and baseline urinary albumin. We pooled data from 49 randomized controlled trials in a meta-analysis using t...

書誌詳細
主要な著者:	Taylor, K, Stevens, R, Blacklock, C, Roberts, N, Pugh, C, Farmer, A, Hirst, J
フォーマット:	Journal article
言語:	English
出版事項:	2012

類似資料

The impact of renin-angiotensin-aldosterone system inhibitors on Type 1 and Type 2 diabetic patients with and without early diabetic nephropathy.
著者:: Hirst, J, 等
出版事項: (2012)

Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis.
著者:: Blacklock, C, 等
出版事項: (2011)

Advances in the Renin-Angiotensin-Aldosterone System: Relevance to Diabetic Nephropathy
著者:: Audrey Koitka, 等
出版事項: (2008-01-01)

Renin Angiotensin Aldosterone System Gene Polymorphisms among Type 2 Diabetic Patients with Retinopathy and Nephropathy
著者:: Vaishali S. Pawar, 等
出版事項: (2024-12-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)
著者:: K. V. Skobeleva, 等
出版事項: (2021-06-01)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
著者:: Yan-Huan Feng, 等
出版事項: (2016-01-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus: the role of renin-angiotensin-aldosterone system (literature review) (part 1)
著者:: K. V. Skobeleva, 等
出版事項: (2021-06-01)

Renin‐Angiotensin‐Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA
著者:: Joshua J. Joseph, 等
出版事項: (2018-09-01)

Network pharmacology combined with Mendelian randomization analysis to identify the key targets of renin-angiotensin-aldosterone system inhibitors in the treatment of diabetic nephropathy
著者:: Dongqi Zhou, 等
出版事項: (2024-01-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Overview of Regulation of the Renin–Angiotensin–Aldosterone System
著者:: Akira Nishiyama, 等
出版事項: (2010-01-01)

The efficacy and safety of dual blockage of the renin-angiotensin-aldosterone system in patients with type 2 diabetes, hypertension and obesity without renal dysfunction
出版事項: (2012-09-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
著者:: Andre Feldman, 等
出版事項: (2020-11-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
著者:: Andre Feldman, 等
出版事項: (2020-11-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
著者:: Andre Feldman, 等
出版事項: (2020-11-01)

Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic
著者:: José Silva-Cardoso, 等
出版事項: (2022-10-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
著者:: D.D. Ivanov
出版事項: (2021-09-01)

Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities
著者:: C. M. Gant, 等
出版事項: (2023-08-01)

Analysis of renin-angiotensin aldosterone system gene polymorphisms in Malaysian essential hypertensive and type 2 diabetic subjects
著者:: Ramachandran, Vasudevan, 等
出版事項: (2009)

Analysis of renin-angiotensin aldosterone system gene polymorphisms in malaysian essential hypertensive and type 2 diabetic subjects
著者:: Stanslas Johnson, 等
出版事項: (2009-02-01)

Association of renin-angiotensin system genes polymorphism with progression of diabetic nephropathy in patients with type 1 diabetes mellitus
著者:: Ilić Vesna, 等
出版事項: (2014-01-01)

Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers
著者:: Yuichiro Ueda, 等
出版事項: (2016-01-01)

Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers
著者:: Yuichiro Ueda, 等
出版事項: (2016-09-01)

Novel Class of Central Renin Angiotensin Aldosterone System Inhibitor: Firibastat
出版事項: (2022-05-01)

Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review
著者:: Filipe Ferrari, 等
出版事項: (2021-04-01)

Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19
著者:: Jordan Loader, 等
出版事項: (2021-08-01)

Genetic polymorphism of renin-angiotensin-aldosterone system in type 2 diabetes and in combination with arterial hypertension among Dagestan inhabitants
著者:: Marat Z. Saidov, 等
出版事項: (2019-12-01)

The renin angiotensin aldosterone system and COVID-19
著者:: Hadeel A. Alsufyani, 等
出版事項: (2020-08-01)

Beyond the circulating renin angiotensin aldosterone system
著者:: Walmor eDe Mello
出版事項: (2014-07-01)

Influence of renin‐angiotensin‐aldosterone system inhibitors on plasma levels of angiotensin‐converting enzyme 2
著者:: Tobias Zimmermann, 等
出版事項: (2021-04-01)

Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia
著者:: Xinwu Huang, 等
出版事項: (2017-06-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Characteristics and Usefulness of the Direct Renin Inhibitor Aliskiren
著者:: Atsuhiro Ichihara, 等
出版事項: (2010-01-01)

Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot Lesions
著者:: Paolo Cimaglia MD, 等
出版事項: (2022-05-01)

A systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy
著者:: Zohreh Rahimi, 等
出版事項: (2014-01-01)

Renin-angiotensin-aldosterone system inhibitors – a realm of confusion in COVID-19
著者:: Angela Madalina Lazar
出版事項: (2021-07-01)

Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients
著者:: Juan Caro-Codón, 等
出版事項: (2022-10-01)

Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea.
著者:: Jungchan Park, 等
出版事項: (2021-01-01)

Efficacy of astragalus combined with renin-angiotensin-aldosterone system blockers in the treatment of stage III diabetic nephropathy: a systematic review and meta-analysis
著者:: Yu-qiong Lin, 等
出版事項: (2024-12-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
著者:: M. L. Maksimov, 等
出版事項: (2010-04-01)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
著者:: Eliecer Coto, 等
出版事項: (2021-03-01)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
著者:: Maricica Pacurari, 等
出版事項: (2014-01-01)